Serina Therapeutics, Inc.(SER) - 2020 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR Delaware 82-1436829 (I.R.S. Employer Identification No.) 1101 Marina Village Parkway, Suite 201 Alameda, California 94501 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (510) 671-8370 Securities registered pursuant to Section 12(b) of the A ...